2,851
edits
Nicotinamide Mononucleotide (NMN): Difference between revisions
Nicotinamide Mononucleotide (NMN) (view source)
Revision as of 04:34, 7 November 2023
, 7 November 2023→Different Forms of NMN
| Line 76: | Line 76: | ||
===α-NMN=== | ===α-NMN=== | ||
α-NMN, on the other hand, does not participate in NAD+ biosynthesis and lacks the biological activity and associated health benefits of β-NMN. It is not the focus of NMN-related research or supplementation. | α-NMN, on the other hand, does not participate in NAD+ biosynthesis and lacks the biological activity and associated health benefits of β-NMN. It is not the focus of NMN-related research or supplementation. | ||
=== Liposomal NMN === | |||
Liposomal NMN is a form of NMN encapsulated within liposomes to enhance stability and bioavailability. As a dietary supplement, liposomal NMN is available on the market, with the liposomal encapsulation aiming to protect the NMN molecule from degradation and to improve its absorption and cellular uptake. This form is being explored for its potential to increase the effectiveness of NMN supplementation by delivering the molecule more efficiently to the cells. | |||
=== MIB-626 === | === MIB-626 === | ||